AS1411-Induced Growth Inhibition of Glioma Cells by Up-Regulation of p53 and Down-Regulation of Bcl-2 and Akt1 via Nucleolin

miR-409-3p suppresses breast cancer cell growth and invasion by targeting Akt1

(2016) Guoqiang Zhang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

The G-quadruplex-forming aptamer AS1411 potently inhibits HIV-1 attachment to the host cell

(2016) Rosalba Perrone et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Quantitative proteomic analysis shows differentially expressed HSPB1 in glioblastoma as a discriminating short from long survival factor and NOVA1 as a differentiation factor between low-grade astrocytoma and oligodendroglioma

(2015) Marcela Gimenez et al.   BMC CANCER

Imp2 regulates GBM progression by activating IGF2/PI3K/Akt pathway

(2015) Qingchun Mu et al.   CANCER BIOLOGY & THERAPY

Interfering with the interaction between ErbB1, nucleolin and Ras as a potential treatment for glioblastoma

(2015) Yona Goldshmit et al.   Oncotarget

A dual functional fluorescent probe for glioma imaging mediated by Blood-brain barrier penetration and glioma cell targeting

(2014) Hongwei Ma et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

In vitro and in vivo Evaluation of Antitumor Drug-Loaded Aptamer Targeted Single-Walled Carbon Nanotubes System

(2014) Huijuan Zhang et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

DNA and RNA Quadruplex-Binding Proteins

(2014) Václav Brázda et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Cell Surface Nucleolin as a Target for Anti-Cancer Therapies

(2014) Marina Koutsioumpa et al.   Recent Patents on Anti-Cancer Drug Discovery

Study and evaluation of mechanisms of dual targeting drug delivery system with tumor microenvironment assays compared with normal assays

(2013) Huile Gao et al.   Acta Biomaterialia

Nucleolar control of p53: a cellular Achilles’ heel and a target for cancer therapy

(2013) Nikolina Vlatković et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma

(2013) Jonathan E. Rosenberg et al.   INVESTIGATIONAL NEW DRUGS

In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation

(2013) Flavia Pichiorri et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Knocking down nucleolin expression in gliomas inhibits tumor growth and induces cell cycle arrest

(2012) Zhiqiang Xu et al.   JOURNAL OF NEURO-ONCOLOGY

RNA-binding protein nucleolin in disease

(2012) Kotb Abdelmohsen et al.   RNA Biology

Insights into the biomedical effects of carboxylated single-wall carbon nanotubes on telomerase and telomeres

(2012) Yong Chen et al.   Nature Communications

Akt signalling in health and disease

(2011) Ingeborg Hers et al.   CELLULAR SIGNALLING

Glycosilated nucleolin as marker for human gliomas

(2011) R. Galzio et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Enhanced translation by Nucleolin via G-rich elements in coding and non-coding regions of target mRNAs

(2011) Kotb Abdelmohsen et al.   NUCLEIC ACIDS RESEARCH

MicroRNA-34a: A Novel Tumor Suppressor in p53-mutant Glioma Cell Line U251

(2010) Shihai Luan et al.   ARCHIVES OF MEDICAL RESEARCH

Post-transcriptional and post-translational regulation of Bcl2: Figure 1

(2010) Shaun Willimott et al.   BIOCHEMICAL SOCIETY TRANSACTIONS

Nucleolin on the Cell Surface as a New Molecular Target for Gastric Cancer Treatment

(2010) Tatsuro Watanabe et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Mechanism of Regulation ofbcl-2mRNA by Nucleolin and A+U-rich Element-binding Factor 1 (AUF1)

(2010) Daniella Ishimaru et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer

(2009) Paula J. Bates et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

(2009) Roger Stupp et al.   LANCET ONCOLOGY

Oncogenic EGFR Signaling Networks in Glioma

(2009) P. H. Huang et al.   Science Signaling

The Nucleolin Targeting Aptamer AS1411 Destabilizes Bcl-2 Messenger RNA in Human Breast Cancer Cells

(2008) S. Soundararajan et al.   CANCER RESEARCH